Recent advances in the molecular pathogenesis of Friedreich ataxia

被引:113
|
作者
Puccio, H [1 ]
Koenig, M [1 ]
机构
[1] Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, ULP, F-67404 Illkirch Graffenstaden, CU De Strasbour, France
关键词
D O I
10.1093/hmg/9.6.887
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Friedreich ataxia, the most frequent cause of recessive ataxia, is due in most cases to a homozygous intronic expansion resulting in the loss of function of frataxin. Frataxin is a mitochondrial protein conserved through evolution. Yeast knock-out models and histological data from patient heart autopsies have shown that frataxin defect causes mitochondrial iron accumulation. Biochemical data from patient heart biopsies or autopsies have revealed a specific deficiency in the activities of aconitases and of mitochondrial iron-sulfur proteins. These results suggest that frataxin may play a role either in mitochondrial iron transport or in iron-sulfur cluster assembly or transport. Iron abnormalities suggest a pathogenic mechanism involving free radical production and oxidative stress, a process that might be sensitive to antioxidant therapies.
引用
收藏
页码:887 / 892
页数:6
相关论文
共 50 条
  • [41] FRIEDREICH ATAXIA
    JOHNSON, WG
    CLINICAL NEUROSCIENCE, 1995, 3 (01) : 33 - 38
  • [42] FRIEDREICH ATAXIA
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1950, 142 (03): : 219 - 219
  • [43] Functional genomic analysis of Friedreich's ataxia pathogenesis in vivo and in vitro
    Coppola, Giovanni
    Engelhardt, Maren
    Suberlak, Matthew N.
    Wexler, Eric M.
    Santos, Manuela
    Pandolfo, Massimo
    Geschwind, Daniel
    NEUROLOGY, 2007, 68 (12) : A407 - A407
  • [44] Mitochondrial dysfunction in Friedreich's ataxia: From pathogenesis to treatment perspectives
    Lodi, R
    Rajagopalan, B
    Bradley, JL
    Taylor, DJ
    Crilley, JG
    Hart, PE
    Blamire, AM
    Manners, D
    Styles, P
    Schapira, AHV
    Cooper, JM
    FREE RADICAL RESEARCH, 2002, 36 (04) : 461 - 466
  • [45] Friedreich ataxia in Norway – an epidemiological, molecular and clinical study
    Iselin Marie Wedding
    Mette Kroken
    Sandra Pilar Henriksen
    Kaja Kristine Selmer
    Torunn Fiskerstrand
    Per Morten Knappskog
    Tone Berge
    Chantal ME Tallaksen
    Orphanet Journal of Rare Diseases, 10
  • [46] Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia
    Becker, E
    Richardson, DR
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (01): : 1 - 10
  • [47] The effect of molecular testing on the diagnostic criteria for Friedreich ataxia
    Pandolfo, M
    Montermini, L
    NEUROLOGY, 1997, 48 (03) : 26006 - 26006
  • [48] MutLα Heterodimers Modify the Molecular Phenotype of Friedreich Ataxia
    Ezzatizadeh, Vahid
    Sandi, Chiranjeevi
    Sandi, Madhavi
    Anjomani-Virmouni, Sara
    Al-Mahdawi, Sahar
    Pook, Mark A.
    PLOS ONE, 2014, 9 (06):
  • [49] Molecular approaches for the treatment and prevention of Friedreich's ataxia
    Yang, Wenyao
    Thompson, Bruce
    Kwa, Faith A. A.
    DRUG DISCOVERY TODAY, 2022, 27 (03) : 866 - 880
  • [50] A protocol for the molecular genetic analysis of Friedreich's Ataxia
    Mountford, R
    McGill, F
    JOURNAL OF MEDICAL GENETICS, 1997, 34 : 1302 - 1302